How employers and TPAs can ease the rising cost of specialty drugs with medical rebates
The pharmaceutical industry is in the middle of a dynamic shift that shows no signs of slowing down. Traditional drug pipelines are now increasingly dominated by specialty drugs, many of which carry a six-figure annual per-patient cost. These drugs have become a driving force behind pharmaceutical expenditure for employer groups and present a challenge for […]
How employers and TPAs can ease the rising cost of specialty drugs with medical rebates Read More »
